论文信息 - Zimeldine treatment of obsessive‐compulsive disorder

Zimeldine treatment of obsessive‐compulsive disorder

ABSTRACT– Six patients with Obsessive‐Compulsive Disorder (DSM III) were treated in an open uncontrolled trial with Zimeldine, for 8 weeks. All six patients had cognitive deficits before treatment. Five patients improved on the clinical symptoms. Four of these showed pronounced amelioration of their cognitive deficits.

H. Westenberg | J. Jolles | R. Kahn | H. G. M. Westenberg

[1] T. Insel,et al. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. , 1983, Archives of general psychiatry.

[2] M. Åsberg,et al. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. , 1980, Archives of general psychiatry.

[3] I. Marks,et al. Clomipramine and Exposure for Obsessive-Compulsive Rituals: 1 , 1980, British Journal of Psychiatry.

[4] Bhagavan Hn,et al. L-tryptophan in obsessive-compulsive disorders. , 1977 .

[5] J. Yaryura-Tobias,et al. L-tryptophan in obsessive-compulsive disorders. , 1977, American Journal of Psychiatry.